US2021346448A1PendingUtilityA1

Therapy for promoting cell growth

69
Assignee: MOLEAC PTE LTDPriority: Mar 27, 2009Filed: Jun 2, 2021Published: Nov 11, 2021
Est. expiryMar 27, 2029(~2.7 yrs left)· nominal 20-yr term from priority
A61K 36/537A61K 45/06A61K 36/736A61K 36/882A61K 36/481A61P 25/24A61K 36/286A61P 25/14A61P 9/10A61K 36/69A61K 36/236A61K 35/62A61P 43/00A61P 25/28A61K 38/00A61P 21/00A61P 9/00A61K 36/232A61P 25/02A61P 25/00A61P 21/02A61P 25/08A61P 25/06A61K 36/65
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

There is disclosed the use of a composition for promoting neuronal growth of neurons in tissues of the central or peripheral nervous system. There is also disclosed a method for inducing proliferation or differentiation of neuronal cells.

Claims

exact text as granted — not AI-modified
1 .- 73 . (canceled) 
     
     
         74 . A composition comprising the following four herbal components:
 i) Radix  Astragali;      ii) Radix  Polygalae;      iii) Rhizoma  Chuanxiong ; and   iv) Radix Angelicae  sinensis,      
       wherein i, ii, iii, and iv are present in the composition in a ratio of about 5:1:1:1 by weight, respectively. 
     
     
         75 . A composition consisting essentially of the following four herbal components:
 i) Radix  Astragali;      ii) Radix  Polygalae;      iii) Rhizoma  Chuanxiong ; and   iv) Radix Angelicae  sinensis,      
       wherein i, ii, iii, and iv are present in the composition in a ratio of about 5:1:1:1 by weight, respectively. 
     
     
         76 . An extraction product of a composition comprising the following four herbal components:
 i) Radix  Astragali;      ii) Radix  Polygalae;      iii) Rhizoma  Chuanxiong ; and   iv) Radix Angelicae  sinensis,      
       wherein i, ii, iii, and iv are present in the composition in a ratio of about 5:1:1:1 by weight, respectively. 
     
     
         77 . An extraction product of a composition consisting essentially of the following four herbal components:
 i) Radix  Astragali;      ii) Radix  Polygalae;      iii) Rhizoma  Chuanxiong ; and   iv) Radix Angelicae  sinensis,      
       wherein i, ii, iii, and iv are present in the composition in a ratio of about 5:1:1:1 by weight, respectively. 
     
     
         78 . The composition according to  claim 74 , wherein said composition is a pharmaceutical composition comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         79 . The composition according to  claim 75 , wherein said composition is a pharmaceutical composition comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         80 . The product according to  claim 76 , wherein said product is a pharmaceutical product comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         81 . The product according to  claim 77 , wherein said product is a pharmaceutical product comprising a pharmaceutically acceptable additive, carrier or diluent. 
     
     
         82 . The product according to  claim 80 , wherein said pharmaceutical product is administered orally. 
     
     
         83 . The product according to  claim 81 , wherein said pharmaceutical product is administered orally. 
     
     
         84 . The product according to  claim 80 , wherein said pharmaceutical product is administered orally as one or more tablets or capsules. 
     
     
         85 . The product according to  claim 81 , wherein said pharmaceutical product is administered orally as one or more tablets or capsules. 
     
     
         86 . The product according to  claim 80 , wherein said pharmaceutical product is used in combination with one or more Western medicines. 
     
     
         87 . The product according to  claim 81 , wherein said pharmaceutical product is used in combination with one or more Western medicines.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.